Trial
NCT04843722
COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
ImmunityBio, Inc.
Collaborators
—
Condition
Covid19
Intervention
hAd5-S-Fusion+N-ETSD vaccine
Why stopped
The sponsor has changed the development plans which is not for safety reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-21